(Q33212361)

24 July 2017

Meta-analysis when only the median survival times are known: a comparison with individual patient data results (English)

1 reference

24 July 2017

1 reference

1 reference

Stefan Michiels

1

0 references

Jean-Pierre Pignon

object named as

Jean-Pierre Pignon

6

0 references

Sarah Burdett

3

object named as

Sarah Burdett

1 reference

24 July 2017

Pascal Piedbois

2

1 reference

PubMed ID

15736523

24 July 2017

Nathalie Syz

4

1 reference

PubMed ID

15736523

24 July 2017

Lesley Stewart

5

1 reference

24 July 2017

1 January 2005

1 reference

International Journal of Technology Assessment in Health Care

24 July 2017

1 reference

24 July 2017

21

1 reference

24 July 2017

119-125

1 reference

24 July 2017

1

1 reference

Confronting publication bias: a cohort design for meta-analysis

24 July 2017

1 reference

https://api.crossref.org/works/10.1017%2FS0266462305050154

Meta-analyses of randomised clinical trials in oncology.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0266462305050154

Individual patient-versus literature-based meta-analysis of survival data: time to event and event rate at a particular time can make a difference, an example based on head and neck cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0266462305050154

Identifying relevant studies for systematic reviews

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0266462305050154

The Cochrane collaboration: preparing, maintaining, and disseminating systematic reviews of the effects of health care

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0266462305050154

Prophylactic cranial irradiation for patients with small-cell lung cancer in complete remission. Prophylactic Cranial Irradiation Overview Collaborative Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0266462305050154

Preoperative radiotherapy in esophageal carcinoma: a meta-analysis using individual patient data (Oesophageal Cancer Collaborative Group).

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0266462305050154

Review of survival analyses published in cancer journals

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0266462305050154

Beta blockade during and after myocardial infarction: an overview of the randomized trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0266462305050154

A meta-analysis of thoracic radiotherapy for small-cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0266462305050154

The CONSORT statement: revised recommendations for improving the quality of reports of parallel-group randomised trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0266462305050154

Bias in the one-step method for pooling study results.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0266462305050154

Chemotherapy in adult high-grade glioma: a systematic review and meta-analysis of individual patient data from 12 randomised trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0266462305050154

Publication bias in clinical research

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0266462305050154

Effects of adjusting for censoring on meta-analyses of time-to-event outcomes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0266462305050154

Is there bias in the publication of individual patient data meta-analyses?

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0266462305050154

Meta-analysis of the literature or of individual patient data: is there a difference?

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0266462305050154

Bias in the analysis and reporting of randomized controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0266462305050154

A two-sample test sensitive to crossing hazards in uncensored and singly censored data

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0266462305050154

Meta-analysis of randomized trials testing the biochemical modulation of fluorouracil by methotrexate in metastatic colorectal cancer. Advanced Colorectal Cancer Meta-Analysis Project

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0266462305050154

7 January 2021

Alpha-interferon does not increase the efficacy of 5-fluorouracil in advanced colorectal cancer

1 reference

https://api.crossref.org/works/10.1017%2FS0266462305050154

7 January 2021

Reappraisal of hepatic arterial infusion in the treatment of nonresectable liver metastases from colorectal cancer

1 reference

https://api.crossref.org/works/10.1017%2FS0266462305050154

7 January 2021

A general parametric approach to the meta-analysis of randomized clinical trials

1 reference

https://api.crossref.org/works/10.1017%2FS0266462305050154

7 January 2021

Extracting summary statistics to perform meta-analyses of the published literature for survival endpoints

1 reference

https://api.crossref.org/works/10.1017%2FS0266462305050154

7 January 2021

Confidence intervals for reporting results of clinical trials

1 reference

https://api.crossref.org/works/10.1017%2FS0266462305050154

7 January 2021

Issues of efficiency in combining proportions of deaths from several clinical trials

1 reference

https://api.crossref.org/works/10.1017%2FS0266462305050154

7 January 2021

Modulation of fluorouracil by leucovorin in patients with advanced colorectal cancer: evidence in terms of response rate. Advanced Colorectal Cancer Meta-Analysis Project

1 reference

https://api.crossref.org/works/10.1017%2FS0266462305050154

7 January 2021

10.1017/S0266462305050154

Identifiers

DOI

1 reference

24 July 2017

1 reference

PubMed ID

15736523